Antenatal care packages with reduced visits and perinatal mortality: a secondary analysis of the WHO Antenatal Care Trial
Open Access
- 12 April 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Reproductive Health
- Vol. 10 (1), 19-7
- https://doi.org/10.1186/1742-4755-10-19
Abstract
In 2001, the WHO Antenatal Care Trial (WHOACT) concluded that an antenatal care package of evidence-based screening, therapeutic interventions and education across four antenatal visits for low-risk women was not inferior to standard antenatal care and may reduce cost. However, an updated Cochrane review in 2010 identified an increased risk of perinatal mortality of borderline statistical significance in three cluster-randomized trials (including the WHOACT) in developing countries. We conducted a secondary analysis of the WHOACT data to determine the relationship between the reduced visits, goal-oriented antenatal care package and perinatal mortality. Exploratory analyses were conducted to assess the effect of baseline risk and timing of perinatal death. Women were stratified by baseline risk to assess differences between intervention and control groups. We used linear modeling and Poisson regression to determine the relative risk of fetal death, neonatal death and perinatal mortality by gestational age. 12,568 women attended the 27 intervention clinics and 11,958 women attended the 26 control clinics. 6,160 women were high risk and 18,365 women were low risk. There were 161 fetal deaths (1.4%) in the intervention group compared to 119 fetal deaths in the control group (1.1%) with an increased overall adjusted relative risk of fetal death (Adjusted RR 1.27; 95% CI 1.03, 1.58). This was attributable to an increased relative risk of fetal death between 32 and 36 weeks of gestation (Adjusted RR 2.24; 95% CI 1.42, 3.53) which was statistically significant for high and low risk groups. It is plausible the increased risk of fetal death between 32 and 36 weeks gestation could be due to reduced number of visits, however heterogeneity in study populations or differences in quality of care and timing of visits could also be playing a role. Monitoring maternal, fetal and neonatal outcomes when implementing antenatal care protocols is essential. Implementing reduced visit antenatal care packages demands careful monitoring of maternal and perinatal outcomes, especially fetal death.Keywords
This publication has 14 references indexed in Scilit:
- Alternative versus standard packages of antenatal care for low-risk pregnancyEmergencias, 2015
- Alternative versus standard packages of antenatal care for low-risk pregnancyPublished by Wiley ,2009
- Randomised controlled trial of two antenatal care models in rural ZimbabweBJOG: An International Journal of Obstetrics and Gynaecology, 2007
- WHO antenatal care randomised trial for the evaluation of a new model of routine antenatal careThe Lancet, 2001
- How effective is antenatal care in preventing maternal mortality and serious morbidity? An overview of the evidencePaediatric and Perinatal Epidemiology, 2001
- Does reducing the frequency of routine antenatal visits have long term effects? Follow up of participants in a randomised controlled trial.BJOG: An International Journal of Obstetrics and Gynaecology, 1999
- The WHO Antenatal Care Randomised Controlled Trial: rationale and study designPaediatric and Perinatal Epidemiology, 1998
- Nutritional and Antimicrobial Interventions to Prevent Preterm BirthObstetrical & Gynecological Survey, 1998
- Does reducing the number of prenatal office visits for low-risk women result in increased use of other medical services?Obstetrics & Gynecology, 1997
- Effectiveness of Interventions to Prevent or Treat Impaired Fetal GrowthObstetrical & Gynecological Survey, 1997